Skip to main content

Gabriel Sampol Rubio

Institutions of which they are part

Pneumology
Vall Hebron Institut de Recerca

Gabriel Sampol Rubio

Institutions of which they are part

Pneumology
Vall Hebron Institut de Recerca

Projects

Síndrome de apneas-hipopneas del sueño en mujeres premenopáusicas con obesidad mórbida incluidas en un programa de cirugía bariátrica. Influencia sobre los factores de riesgo cardiovascular: activación simpática, inflamación y resistencia a la insulina

IP: -
Collaborators: Odile Romero Santo-Tomas, Jose Manuel Fort López-Barajas, Gabriel Sampol Rubio
Funding agency: Instituto de Salud Carlos III
Funding: 25410
Reference: PI060476
Duration: 01/01/2007 - 30/12/2009

Investigación cooperativa en enfermedades respiratorias

IP: Ferran Morell Brotad
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Carles Bravo Masgoret, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Jaume Ferrer Sancho, Mª Jesús Cruz Carmona, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 43435
Reference: PI051344
Duration: 01/01/2006 - 31/12/2006

Bases moleculares y fisiológicas de las enfermedades respiratorias. Implicaciones diagnósticas y terapéuticas.

IP: Ferran Morell Brotad
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Odile Romero Santo-Tomas, Carles Bravo Masgoret, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Jaume Ferrer Sancho, Mª Jesús Cruz Carmona, Albert Selva O'Callaghan, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 264070
Reference: C03/11
Duration: 01/01/2003 - 31/12/2005

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Laura Gonzalez Garcia

Laura Gonzalez Garcia

Growth and Development
Read more
Rosa Lloria Verges

Rosa Lloria Verges

Administration and Management
Pneumology
Read more
Xavier Nuvials Casals

Xavier Nuvials Casals

Shock, Organ Dysfunction and Resuscitation
Read more
Marian Del Hoyo Martín

Marian Del Hoyo Martín

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.